Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413777
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2006-12-18
Brief Title:
Tolvaptan Open-label Pilot Efficacy Tolerability and Safety Study in Autosomal Dominant Polycystic Kidney Disease ADPKD
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Polycystic Kidney Autosomal Dominant |
Keywords: